{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:07:03Z","timestamp":1788923223591,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["neuromodulationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromodulation: Technology at the Neural Interface"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1111\/j.1525-1403.2012.00479.x","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T14:25:10Z","timestamp":1341239110000},"page":"508-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Pharmacokinetic Analysis of Ziconotide (SNX-111), an Intrathecal N-Type Calcium Channel Blocking Analgesic, Delivered by Bolus and Infusion in the Dog"],"prefix":"10.1016","volume":"15","author":[{"given":"Tony L.","family":"Yaksh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"de Kater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brookie M.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Miljanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1525-1403.2012.00479.x_bib1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.4071055","article-title":"Peptide neurotoxins from fish-hunting cone snails","volume":"230","author":"Olivera","year":"1985","journal-title":"Science"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib2","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1021\/bi00025a013","article-title":"Structure-activity analysis of a Conus peptide blocker of N-type neuronal calcium channels","volume":"34","author":"Nadasdi","year":"1995","journal-title":"Biochemistry"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib3","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1016\/S0021-9258(19)84552-0","article-title":"Calcium channel antagonists. Omega-conotoxin defines a new high affinity site","volume":"261","author":"Cruz","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib4","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.1073\/pnas.83.22.8804","article-title":"Brain voltage-sensitive calcium channel subtypes differentiated by omega-conotoxin fraction GVIA","volume":"83","author":"Reynolds","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib5","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.2174\/0929867043363884","article-title":"Ziconotide: neuronal calcium channel blocker for treating severe chronic pain","volume":"11","author":"Miljanich","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/ALN.0b013e31821950c2","article-title":"Regulation of spinal substance P release by intrathecal calcium channel blockade","volume":"115","author":"Takasusuki","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0022-3565(25)38848-8","article-title":"Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia","volume":"269","author":"Chaplan","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0304-3959(94)00094-U","article-title":"Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats","volume":"60","author":"Malmberg","year":"1995","journal-title":"Pain"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib9","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1523\/JNEUROSCI.14-08-04882.1994","article-title":"Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception","volume":"14","author":"Malmberg","year":"1994","journal-title":"J Neurosci"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0022-3565(25)21283-6","article-title":"Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain","volume":"279","author":"Bowersox","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0006-8993(94)90398-0","article-title":"Neuroanatomical distribution of receptors for a novel voltage-sensitive calcium-channel antagonist, SNX-230 (omega-conopeptide MVIIC)","volume":"653","author":"Gohil","year":"1994","journal-title":"Brain Res"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0165-6147(99)01370-X","article-title":"Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models","volume":"20","author":"Yaksh","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002508-199709000-00012","article-title":"Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain","volume":"13","author":"Brose","year":"1997","journal-title":"Clin J Pain"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib14","first-page":"274","article-title":"Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain","volume":"25","author":"Atanassoff","year":"2000","journal-title":"Reg Anesth Pain Med"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/0091270003253349","article-title":"Pharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patients","volume":"43","author":"Wermeling","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1533-2500.2009.00303.x","article-title":"Intrathecal ziconotide for neuropathic pain: a review","volume":"9","author":"Rauck","year":"2009","journal-title":"Pain Pract"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(99)00255-9","article-title":"Ziconotide for the treatment of severe spasticity after spinal cord injury","volume":"85","author":"Ridgeway","year":"2000","journal-title":"Pain"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0304-3959(99)00254-7","article-title":"Adverse effects associated with the intrathecal administration of ziconotide","volume":"85","author":"Penn","year":"2000","journal-title":"Pain"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/faat.1997.2314","article-title":"Kinetic and safety studies on intrathecally infused recombinant-methionyl human brain-derived neurotrophic factor in dogs","volume":"38","author":"Yaksh","year":"1997","journal-title":"Fundam Appl Toxicol"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00000542-199502000-00012","article-title":"Studies on the safety of chronically administered intrathecal neostigmine methylsulfate in rats and dogs","volume":"82","author":"Yaksh","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00000542-200307000-00028","article-title":"Chronically infused intrathecal morphine in dogs","volume":"99","author":"Yaksh","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/00000542-199410000-00017","article-title":"Spinal delivery of sufentanil, alfentanil, and morphine in dogs. Physiologic and toxicologic investigations","volume":"81","author":"Sabbe","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib25","first-page":"379","article-title":"Pharmacokinetics of SNX-111, a selective N-type calcium channel blocker, in rats and cynomolgus monkeys","volume":"25","author":"Bowersox","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib26","series-title":"Spinal drug delivery","first-page":"317","article-title":"Animal models of intrathecal and epidural drug delivery","author":"Yaksh","year":"1999"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib27","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/00000542-199405000-00015","article-title":"Spinal and systemic action of the alpha2 receptor agonist dexmedetomidine in dogs. Antinociception and carbon dioxide response","volume":"80","author":"Sabbe","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/faat.1994.1112","article-title":"Pharmacology and toxicology of chronically infused epidural clonidine HCl in dogs","volume":"23","author":"Yaksh","year":"1994","journal-title":"Fundam Appl Toxicol"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/toxsci\/kfh168","article-title":"Intrathecal ketorolac in dogs and rats","volume":"80","author":"Yaksh","year":"2004","journal-title":"Toxicol Sci"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1018916802528","article-title":"Pharmacokinetic analysis of drug absorption from muscle based on a physiological diffusion model: effect of molecular size on absorption","volume":"9","author":"Nara","year":"1992","journal-title":"Pharm Res"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1213\/00000539-198606000-00005","article-title":"Distribution in cerebrospinal fluid, blood, and lymph of epidurally injected morphine and inulin in dogs","volume":"65","author":"Durant","year":"1986","journal-title":"Anesth Analg"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1113\/jphysiol.1983.sp014731","article-title":"Factors influencing exit of substances from cerebrospinal fluid into deep cervical lymph of the rabbit","volume":"339","author":"Bradbury","year":"1983","journal-title":"J Physiol"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0887-2171(00)90037-4","article-title":"The quantitative evaluation of cerebral spinal fluid flow","volume":"21","author":"Kizziar","year":"2000","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1115\/1.1336144","article-title":"Hydrodynamic modeling of cerebrospinal fluid motion within the spinal cavity","volume":"123","author":"Loth","year":"2001","journal-title":"J Biomech Eng"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/bean.2002.0255","article-title":"Understanding the physiology and pharmacology of epidural and intrathecal opioids","volume":"16","author":"Bernards","year":"2002","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib36","series-title":"Spinal drug delivery","first-page":"177","article-title":"Spinal cerebrospinal fluid chemistry and physiology","author":"Artru","year":"1999"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00000542-200003000-00018","article-title":"Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil [see comments]","volume":"92","author":"Ummenhofer","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0196-9781(00)00175-3","article-title":"Bioavailability of ziconotide in brain: influx from blood, stability, and diffusion","volume":"21","author":"Newcomb","year":"2000","journal-title":"Peptides"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/cne.902610409","article-title":"Regionally selective elimination of cutaneous thermal nociception in rats by neonatal capsaicin","volume":"261","author":"Doucette","year":"1987","journal-title":"J Comp Neurol"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib40","doi-asserted-by":"crossref","first-page":"7894","DOI":"10.1073\/pnas.90.16.7894","article-title":"A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia","volume":"90","author":"Valentino","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib41","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1460-9568.1996.tb01336.x","article-title":"Inhibition of N-type calcium channels: the only mechanism by which presynaptic alpha 2-autoreceptors control sympathetic transmitter release","volume":"8","author":"Boehm","year":"1996","journal-title":"Eur J Neurosci"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.bjp.0700948","article-title":"Role of N-, P- and Q-type voltage-gated calcium channels in transmitter release from sympathetic neurones in the mouse isolated vas deferens","volume":"120","author":"Waterman","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00005344-199709000-00019","article-title":"Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humans","volume":"30","author":"McGuire","year":"1997","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib44","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/sj.bjp.0703701","article-title":"Cardiovascular and autonomic effects of omega-conotoxins MVIIA and CVID in conscious rabbits and isolated tissue assays","volume":"131","author":"Wright","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib45","first-page":"756","article-title":"Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action","volume":"20","author":"Bowersox","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib46","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00000542-199104000-00021","article-title":"Site of hemodynamic effects of intrathecal alpha 2-adrenergic agonists [see comments]","volume":"74","author":"Eisenach","year":"1991","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib47","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00000542-198306000-00005","article-title":"Dose-response suppression of noxiously evoked activity of WDR neurons by spinally administered fentanyl","volume":"58","author":"Suzukawa","year":"1983","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00000542-198303000-00005","article-title":"Suppression of noxiously evoked WDR dorsal horn neuronal activity by spinally administered morphine","volume":"58","author":"Homma","year":"1983","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib49","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1517\/13543784.9.10.2403","article-title":"An evaluation of intrathecal ziconotide for the treatment of chronic pain","volume":"9","author":"Jain","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1111\/j.1525-1403.2012.00479.x_bib50","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/TCRM.S4438","article-title":"Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain","volume":"5","author":"Smith","year":"2009","journal-title":"Ther Clin Risk Manag"}],"container-title":["Neuromodulation: Technology at the Neural Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1403.2012.00479.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715912600555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715912600555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1525-1403.2012.00479.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:49:20Z","timestamp":1761083360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094715912600555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1094715912600555"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1403.2012.00479.x","relation":{},"ISSN":["1094-7159"],"issn-type":[{"value":"1094-7159","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic Analysis of Ziconotide (SNX-111), an Intrathecal N-Type Calcium Channel Blocking Analgesic, Delivered by Bolus and Infusion in the Dog","name":"articletitle","label":"Article Title"},{"value":"Neuromodulation: Technology at the Neural Interface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1525-1403.2012.00479.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}